Trial Profile
Clinical Trials Insight: 700052513
Status:
Planning
Phase of Trial:
Phase IV
Latest Information Update: 13 Jan 2010
Price :
$35
*
At a glance
- Drugs Insulin (Primary)
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors MannKind Corporation
- 11 Jan 2010 New trial record.